Roldán-Valadez E

Idioma: Español
Referencias bibliográficas: 28
Paginas: 112-114
Archivo PDF: 87.72 Kb.

FRAGMENTO

Con la publicación exitosa del primer mapa del genoma humano el 26 de junio de 2000,1 quedó claro que había iniciado una nueva era de descubrimientos y avances médicos. Pareciera que la brecha entre la Radiología y la investigación biomédica se acrecenta, sin embargo, ocurre lo contrario: cada día más departamentos de Radiología en las instituciones académicas de los Estados Unidos interactúan con centros de investigación en medicina molecular y reciben más apoyos del gobierno de ese país; como lo demuestra la reciente creación del “Laboratorio de Imagen Molecular” del Programa de Ciencias de la Imagen en los Institutos Nacionales de Salud (NIH) de los Estados Unidos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Pennisi E., Human genome. Finally, the book of life and instructions for navigating it. Science, 2000; 288:2304-7.

2. Brown P.O. and D. Botstein, Exploring the new world of the genome with DNA microarrays. Nat Genet, 1999;21:33-7.

3. Wu T.D., Analysing gene expression data from DNA microarrays to identify candidate genes. J Pathol, 2001;195:53-65.

4. Kao C.M., Functional genomic technologies: creating new paradigms for fundamental and applied biology. Biotechnol Prog, 1999;15:304-11.

5. Graves P.R. and T.A. Haystead, Molecular biologist’s guide to proteomics. Microbiol Mol Biol Rev, 2002;66: 39-63; table of contents.

6. Miklos G.L. and R. Maleszka, Integrating molecular medicine with functional proteomics: realities and expectations. Proteomics, 2001;1:30-41.

7. Gillett C.E., et al., Multiple tissue core arrays in histopathology research: a validation study. J Pathol, 2000;192:549-53.

8. Hoos A., et al., Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol, 2001;158:1245-51.

9. Luscombe N.M., D. Greenbaum, and M. Gerstein, What is bioinformatics? A proposed definition and overview of the field. Methods Inf Med, 2001;40:346- 58.

10. Sorlie T., et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A, 2001;98:10869-74.

11. van ‘t Veer, L.J., et al., Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002;415:530-6.

12. Liefers G.J. and R.A. Tollenaar, Cancer genetics and their application to individualised medicine. Eur J Cancer, 2002;38:872-9.

13. Lakhani S.R. and A. Ashworth, Microarray and histopathological analysis of tumours: the future and the past? Nat Rev Cancer, 2001;1:151-7.

14. Li, K.C., Biomedical imaging in the postgenomic era: opportunities and challenges. Acad Radiol, 2002;9:999-1003.

15. Bremer C. and R. Weissleder, In vivo imaging of gene expression. Acad Radiol, 2001;8:15-23.

16. Luker G.D. and D. Piwnica-Worms, Molecular imaging in vivo with PET and SPECT. Acad Radiol, 2001;8:4-14.

17. Patani G.A. and E.J. LaVoie, Bioisosterism: A Rational Approach in Drug Design. Chem Rev, 1996;96:3147- 3176.

18. Wlodawer A., Rational approach to AIDS drug design through structural biology. Annu Rev Med, 2002;53:595-614.

19. Suleman, A. and E.B. Skibo, A comprehensive study of the active site residues of DT-diaphorase: rational design of benzimidazolediones as DT-diaphorase substrates. J Med Chem, 2002;45:1211-20.

20. Shoemaker R.H., et al., Application of high-throughput, molecular-targeted screening to anticancer drug discovery. Curr Top Med Chem, 2002;2:229-46.

21. Tropsha A. and W. Zheng, Rational principles of compound selection for combinatorial library design. Comb Chem High Throughput Screen, 2002;5:111- 23.

22. Li K.C., Special issue: Molecular imaging. J Magn Reson Imaging, 2002;16:335.

23. Akhurst T. and R. Chisin, Hybrid PET/CT machines: optimized PET machines for the new millennium? J Nucl Med, 2000;41:961-3.

24. Beyer T., et al., A combined PET/CT scanner for clinical oncology. J Nucl Med, 2000;41:1369-79.

25. Charron M., et al., Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med, 2000;25:905-10.

26. Bhatnagar A., R. Hustinx, and A. Alavi, Nuclear imaging methods for non-invasive drug monitoring. Adv Drug Deliv Rev, 2000;41:41-54.

27. Storrs R.W., et al., Paramagnetic polymerized liposomes as new recirculating MR contrast agents. J Magn Reson Imaging, 1995;5:719-24.

28. Sipkins, D.A., et al., Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med, 1998;4:623-6.